These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4618285)

  • 1. Behavioral effects of a new dopamine-beta-hydroxylase inhibitor (fusaric acid) in man.
    Goodwin FK; Sack RL
    J Psychiatr Res; 1974; 11():211-7. PubMed ID: 4618285
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of dopamine-b-hydroxylase in manic patients. A clinical trial and fusaric acid.
    Sack RL; Goodwin FK
    Arch Gen Psychiatry; 1974 Nov; 31(5):649-54. PubMed ID: 4613319
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of fusaric acid (a dopamine beta-hydroxylase inhibitor) on phaeochromocytoma.
    Nagasaka A; Hara I; Imai Y; Uchikawa T; Yamauchi K; Suzuki S; Takatsuki K; Tomita A; Niinomi M; Nakagawa H
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):437-44. PubMed ID: 3987067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of fusaric acid calcium on catecholamine metabolism and its clinical effects on essential hypertension].
    Ozawa M; Nakajima Y; Suzuki K; Sato T; Takahashi E
    Horumon To Rinsho; 1976 Jan; 24(1):79-86. PubMed ID: 942902
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of clozapine on the excretion of 3-methoxy-4-hydroxy-phenylglycol, homovanillic acid and 5-hydroxy-indole acetic acid in urine and cerebrospinal fluid].
    Ackenheil M; Beckmann H; Hoffmann G; Markianos E; Nyström I; Raese J
    Arzneimittelforschung; 1974 Jul; 24(7):984-7. PubMed ID: 4408052
    [No Abstract]   [Full Text] [Related]  

  • 6. Fusaric acid-induced elevation of homovanillic acid in the CSF as an index of brain noradrenaline synthesis.
    Elghozi JL; Laude D; Chaouloff F
    Eur J Pharmacol; 1985 Nov; 117(3):363-7. PubMed ID: 4076351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine beta-hydroxylase inhibition in a patient with Wilson's disease and manic symptoms.
    Pandey RS; Sreenivas KN; Patil NM; Swamy HS
    Am J Psychiatry; 1981 Dec; 138(12):1628-9. PubMed ID: 7304799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man.
    Ackenheil M; Beckmann H; Greil W; Hoffmann G; Markianos E; Raese J
    Adv Biochem Psychopharmacol; 1974; 9(0):647-57. PubMed ID: 4836227
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of fusaric acid on tardive dyskinesia and mental state in psychogeriatric patients. A pilot study.
    Viukari M; Linnoila M
    Acta Psychiatr Scand; 1977 Jul; 56(1):57-61. PubMed ID: 331875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology of schizophrenia: Mental effects of dopamine-beta-hydroxylase inhibition in normal men.
    Hartmann E; Keller-Teschke M
    Lancet; 1977 Jan; 1(8001):37-8. PubMed ID: 63668
    [No Abstract]   [Full Text] [Related]  

  • 11. The long-term hemodynamic effect of fusaric acid in elderly hypertensive patients.
    Terasawa F; Ying LH; Suzuki T
    Jpn Circ J; 1976 Sep; 40(9):1025-31. PubMed ID: 994314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 5-(substituted alkyl) picolinic acids. The dopamine beta-hydroxylase inhibitors. II.
    Miyano K; Sakasai T; Hamano H
    Chem Pharm Bull (Tokyo); 1978 Aug; 26(8):2328-33. PubMed ID: 709695
    [No Abstract]   [Full Text] [Related]  

  • 13. Fusaric acid in Parkinson's disease.
    Chase TN
    Neurology; 1974 Jul; 24(7):637-9. PubMed ID: 4858086
    [No Abstract]   [Full Text] [Related]  

  • 14. Time-course changes in blood pressure, urinary excretion of norepinephrine and dopamine after administration of fusaric acid in a single dose in elderly hypertensive patients.
    Terasawa F; Hidaka H
    Jpn Circ J; 1976 Jul; 40(7):785-91. PubMed ID: 987254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24-hour rhythm of human plasma noradrenaline and the effect of fusaric acid, a dopamine-beta-hydroxylase inhibitor.
    Kato T; Hashimoto Y; Nagatsu T; Shinoda T; Okada T; Takeuchi T; Umezawa H
    Neuropsychobiology; 1980; 6(2):61-5. PubMed ID: 7354907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a peripheral effect of fusaric acid, a dopamine beta-hydroxylase inhibitor, on serotonin metabolism.
    Bonnay MM; Guerinot F; Bohuon CJ
    Biochem Pharmacol; 1974 Oct; 23(19):2770-3. PubMed ID: 4419680
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary norepinephrine excretion in elderly hypertensive patients during administration of fusaric acid.
    Terasawa F; Ying LH; Suzuki T; Hidaka H
    Jpn Circ J; 1976 Sep; 40(9):1033-7. PubMed ID: 994315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution to the biochemical treatment of the Parkinson's disease (author's transl)].
    Calatayud Maldonado V
    Rev Esp Otoneurooftalmol Neurocir; 1978; 36(204):33-41. PubMed ID: 741072
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antihypertensive effect of trifluoropentoxypicolinic acid: a pharmacokinetic study].
    Horisaka K; Masuda S
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):301-7. PubMed ID: 6745810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human serum dopamine -hydroxylase after the oral administration of fusaric acid.
    Nagatsu T; Kato T; Kuzuya H; Okada T; Umezawa H; Takeuchi T
    Experientia; 1972 Jul; 28(7):779-80. PubMed ID: 4658852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.